PMC:7161517 / 22450-22768 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T134","span":{"begin":133,"end":138},"obj":"Body_part"},{"id":"T135","span":{"begin":297,"end":303},"obj":"Body_part"}],"attributes":[{"id":"A134","pred":"fma_id","subj":"T134","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A135","pred":"fma_id","subj":"T135","obj":"http://purl.org/sig/ont/fma/fma9637"}],"text":"Diabetic Patients Treated With Antihypertensive Drugs; NCT00192803); and 2) the overexpression of ACE2/Ang 1-7 in cardiac progenitor cells to assess for enhancement in reparative function and the potential to attenuate myocardial ischemia−induced cardiac damage (Cardiovascular Disease Protection Tissue; NCT02348515)."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T68","span":{"begin":297,"end":303},"obj":"Body_part"}],"attributes":[{"id":"A68","pred":"uberon_id","subj":"T68","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"Diabetic Patients Treated With Antihypertensive Drugs; NCT00192803); and 2) the overexpression of ACE2/Ang 1-7 in cardiac progenitor cells to assess for enhancement in reparative function and the potential to attenuate myocardial ischemia−induced cardiac damage (Cardiovascular Disease Protection Tissue; NCT02348515)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T97","span":{"begin":219,"end":238},"obj":"Disease"},{"id":"T98","span":{"begin":230,"end":238},"obj":"Disease"},{"id":"T99","span":{"begin":263,"end":285},"obj":"Disease"}],"attributes":[{"id":"A97","pred":"mondo_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/MONDO_0024644"},{"id":"A98","pred":"mondo_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/MONDO_0005053"},{"id":"A99","pred":"mondo_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/MONDO_0004995"}],"text":"Diabetic Patients Treated With Antihypertensive Drugs; NCT00192803); and 2) the overexpression of ACE2/Ang 1-7 in cardiac progenitor cells to assess for enhancement in reparative function and the potential to attenuate myocardial ischemia−induced cardiac damage (Cardiovascular Disease Protection Tissue; NCT02348515)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T222","span":{"begin":133,"end":138},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"Diabetic Patients Treated With Antihypertensive Drugs; NCT00192803); and 2) the overexpression of ACE2/Ang 1-7 in cardiac progenitor cells to assess for enhancement in reparative function and the potential to attenuate myocardial ischemia−induced cardiac damage (Cardiovascular Disease Protection Tissue; NCT02348515)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T141","span":{"begin":0,"end":318},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Diabetic Patients Treated With Antihypertensive Drugs; NCT00192803); and 2) the overexpression of ACE2/Ang 1-7 in cardiac progenitor cells to assess for enhancement in reparative function and the potential to attenuate myocardial ischemia−induced cardiac damage (Cardiovascular Disease Protection Tissue; NCT02348515)."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T33","span":{"begin":263,"end":285},"obj":"Phenotype"}],"attributes":[{"id":"A33","pred":"hp_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/HP_0001626"}],"text":"Diabetic Patients Treated With Antihypertensive Drugs; NCT00192803); and 2) the overexpression of ACE2/Ang 1-7 in cardiac progenitor cells to assess for enhancement in reparative function and the potential to attenuate myocardial ischemia−induced cardiac damage (Cardiovascular Disease Protection Tissue; NCT02348515)."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T771","span":{"begin":48,"end":53},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T772","span":{"begin":80,"end":94},"obj":"GO:0010467"},{"id":"T773","span":{"begin":98,"end":102},"obj":"G_3;PG_10;PR:000003622"},{"id":"T774","span":{"begin":103,"end":110},"obj":"PR:000036013"},{"id":"T775","span":{"begin":114,"end":121},"obj":"UBERON:0000948"},{"id":"T776","span":{"begin":219,"end":229},"obj":"UBERON:0002349"},{"id":"T777","span":{"begin":247,"end":254},"obj":"UBERON:0000948"},{"id":"T778","span":{"begin":263,"end":277},"obj":"UBERON:0004535"},{"id":"T779","span":{"begin":297,"end":303},"obj":"UBERON:0000479"},{"id":"T25778","span":{"begin":40,"end":48},"obj":"SP_7"},{"id":"T84221","span":{"begin":68,"end":75},"obj":"UBERON:0000948"},{"id":"T89571","span":{"begin":146,"end":154},"obj":"SP_7"},{"id":"T85711","span":{"begin":209,"end":228},"obj":"PR:000005897"},{"id":"T57094","span":{"begin":290,"end":300},"obj":"UBERON:0002349"}],"text":"Diabetic Patients Treated With Antihypertensive Drugs; NCT00192803); and 2) the overexpression of ACE2/Ang 1-7 in cardiac progenitor cells to assess for enhancement in reparative function and the potential to attenuate myocardial ischemia−induced cardiac damage (Cardiovascular Disease Protection Tissue; NCT02348515)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"978","span":{"begin":98,"end":102},"obj":"Gene"},{"id":"979","span":{"begin":103,"end":110},"obj":"Gene"},{"id":"983","span":{"begin":9,"end":17},"obj":"Species"},{"id":"988","span":{"begin":0,"end":8},"obj":"Disease"},{"id":"989","span":{"begin":219,"end":238},"obj":"Disease"},{"id":"990","span":{"begin":247,"end":261},"obj":"Disease"},{"id":"991","span":{"begin":263,"end":285},"obj":"Disease"}],"attributes":[{"id":"A978","pred":"tao:has_database_id","subj":"978","obj":"Gene:59272"},{"id":"A979","pred":"tao:has_database_id","subj":"979","obj":"Gene:284"},{"id":"A983","pred":"tao:has_database_id","subj":"983","obj":"Tax:9606"},{"id":"A988","pred":"tao:has_database_id","subj":"988","obj":"MESH:D003920"},{"id":"A989","pred":"tao:has_database_id","subj":"989","obj":"MESH:D003324"},{"id":"A990","pred":"tao:has_database_id","subj":"990","obj":"MESH:D006331"},{"id":"A991","pred":"tao:has_database_id","subj":"991","obj":"MESH:D002318"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Diabetic Patients Treated With Antihypertensive Drugs; NCT00192803); and 2) the overexpression of ACE2/Ang 1-7 in cardiac progenitor cells to assess for enhancement in reparative function and the potential to attenuate myocardial ischemia−induced cardiac damage (Cardiovascular Disease Protection Tissue; NCT02348515)."}